Amoéba S.A. (LON:0RAE)

Market Cap	48.07M +24.8%
Revenue (ttm)	n/a
Net Income	-7.24M
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,375
Average Volume	452,223
Open	0.7820
Previous Close	0.8090
Day's Range	0.7815 - 0.8000
52-Week Range	0.7500 - 1.4280
Beta	0.05
RSI	32.97
Earnings Date	Apr 17, 2026

About Amoéba

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. Amoéba S.A. was incorporated in 2010 and is based in Chassieu, France.

• Industry: Miscellaneous Chemical Products
• Founded: 2010
• Employees: 20
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RAE

Financial Performance

Financial numbers in EUR